- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.
Progenics Pharmaceuticals Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased to $-0.01 in the quarter versus EPS of $-0.32 in the year-earlier quarter.
Revenue: Rose 303.64% to $8.88 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Progenics Pharmaceuticals Inc. reported adjusted EPS loss of $0.01 per share. By that measure, the company beat the mean analyst estimate of $-0.31. It beat the average revenue estimate of $1.16 million.
Quoting Management: There was no comment from management.
Key Stats (on next page)…
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.